Ingalls & Snyder LLC’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Sell
9,094
-250
-3% -$38.6K 0.05% 194
2025
Q4
$1.45M Buy
9,344
+569
+6% +$85.2K 0.05% 193
2025
Q3
$1.22M Sell
8,775
-41
-0.5% -$5.55K 0.04% 212
2025
Q2
$1.19M Sell
8,816
-147
-2% -$19.9K 0.04% 207
2025
Q1
$1.31M Sell
8,963
-91
-1% -$13.2K 0.04% 200
2024
Q4
$1.25M Buy
9,054
+30
+0.3% +$4.39K 0.05% 198
2024
Q3
$1.39M Buy
9,024
+30
+0.3% +$4.55K 0.05% 197
2024
Q2
$1.31M Buy
8,994
+408
+5% +$58.5K 0.06% 186
2024
Q1
$1.27M Sell
8,586
-855
-9% -$123K 0.06% 193
2023
Q4
$1.29M Sell
9,441
-265
-3% -$34.5K 0.06% 187
2023
Q3
$1.25M Buy
9,706
+619
+7% +$82.2K 0.06% 187
2023
Q2
$1.21M Sell
9,087
-384
-4% -$50.6K 0.06% 192
2023
Q1
$1.23M Buy
9,471
+168
+2% +$21.9K 0.06% 182
2022
Q4
$1.26M Buy
9,303
+1,827
+24% +$242K 0.07% 179
2022
Q3
$905K Buy
7,476
+769
+11% +$99.1K 0.05% 205
2022
Q2
$860K Hold
6,707
0.04% 219
2022
Q1
$919K Sell
6,707
-231
-3% -$30.6K 0.04% 234
2021
Q4
$977K Buy
6,938
+150
+2% +$19.9K 0.04% 231
2021
Q3
$864K Buy
6,788
+45
+0.7% +$5.95K 0.04% 250
2021
Q2
$849K Buy
6,743
+160
+2% +$19.6K 0.04% 253
2021
Q1
$768K Sell
6,583
-155
-2% -$17.9K 0.04% 248
2020
Q4
$764K Buy
6,738
+515
+8% +$56.2K 0.04% 247
2020
Q3
$656K Buy
6,223
+428
+7% +$45K 0.05% 223
2020
Q2
$580K Sell
5,795
-84
-1% -$8.29K 0.03% 241
2020
Q1
$521K Sell
5,879
-8,829
-60% -$858K 0.04% 258
2019
Q4
$1.5M Buy
14,708
+238
+2% +$22.9K 0.08% 160
2019
Q3
$1.3M Sell
14,470
-5,223
-27% -$477K 0.06% 190
2019
Q2
$1.82M Buy
19,693
+725
+4% +$65.2K 0.09% 163
2019
Q1
$1.74M Buy
18,968
+2,157
+13% +$194K 0.08% 168
2018
Q4
$1.45M Sell
16,811
-2,106
-11% -$191K 0.08% 173
2018
Q3
$1.8M Buy
18,917
+86
+0.5% +$7.77K 0.08% 174
2018
Q2
$1.57M Buy
18,831
+379
+2% +$31.4K 0.07% 169
2018
Q1
$1.5M Buy
18,452
+996
+6% +$84.8K 0.07% 169
2017
Q4
$1.44M Sell
17,456
-6,808
-28% -$561K 0.07% 179
2017
Q3
$1.98M Buy
24,264
+2,788
+13% +$224K 0.1% 133
2017
Q2
$1.7M Buy
21,476
+5,540
+35% +$422K 0.09% 145
2017
Q1
$1.19M Buy
15,936
+5,944
+59% +$433K 0.06% 184
2016
Q4
$689K Buy
9,992
+3,149
+46% +$219K 0.04% 228
2016
Q3
$493K Buy
6,843
+96
+1% +$7.07K 0.03% 251
2016
Q2
$484K Buy
+6,747
New +$475K 0.03% 258

Other funds holding XLV

Ingalls & Snyder LLC's XLV Position: Q1 2026 in Review

Ingalls & Snyder LLC reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 2.7% in Q1 2026, selling an estimated $38.6K and leaving 9,094 shares worth $1.33M. The position accounts for 0.05% of the portfolio, ranked #194.

Ingalls & Snyder LLC first reported a position in XLV in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.98M in Q3 2017. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Ingalls & Snyder LLC held 9,094 shares of State Street Health Care Select Sector SPDR ETF worth $1.33M as of Q1 2026.
  • Ingalls & Snyder LLC sold 250 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $38.6K.
  • State Street Health Care Select Sector SPDR ETF made up 0.05% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #194 holding.
  • Ingalls & Snyder LLC first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2016 and has held it in 40 quarters since.
  • Ingalls & Snyder LLC's State Street Health Care Select Sector SPDR ETF position peaked at $1.98M in Q3 2017.
  • 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.